Healthcare - Biotechnology - NASDAQ - US
$ 1.77
-8.29 %
$ 78.9 M
Market Cap
-1.16
P/E
INCOME STATEMENT
19.9 M
REVENUE
-40.5 M
OPERATING INCOME
-37.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Werewolf Therapeutics, Inc.
| Revenue | 19.9 M |
| Cost Of Revenue | 38.9 M |
| Gross Profit | -19 M |
| Operating Expenses | 60.4 M |
| Operating Income | -40.5 M |
| Other Expenses | -3.14 M |
| Net Income | -37.4 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 19.9 | 16.4 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 38.9 | 2.5 | 0.7 | 0.8 | 0.5 |
| Gross Profit | (19.0) | 13.9 | (0.7) | (0.8) | (0.5) |
| OPERATING INCOME | |||||
| Operating Expenses | 60.4 | 72.5 | 50.1 | 22.4 | 9.9 |
| Selling, General and Administrative Expenses | 18.7 | 18.7 | 14.8 | 5.8 | 3.6 |
| Research and Development Expenses | 41.8 | 53.8 | 35.3 | 16.6 | 6.3 |
| Operating Income | (40.5) | (56.1) | (50.1) | (22.4) | (9.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 3.1 | 0 | 0 | 0 | 0.4 |
| Total Other Income | 3.1 | 2.2 | 0.1 | 7.4 | (0.3) |
| Pre-Tax Income | (37.4) | (53.8) | (50.0) | (15.0) | (10.2) |
| NET INCOME | |||||
| Tax Provision | 0 | (2.2) | (0.2) | (0.1) | 0.7 |
| Net Income | (37.4) | (51.6) | (49.8) | (14.9) | (11.0) |
| EPS | 1.05 | 1.79 | 1.82 | 0.52 | 0.38 |